● Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

Condition: Secondary Progressive Multiple Sclerosis (SPMS) · Sponsor: Novartis Pharmaceuticals

PhasePhase 3

Planned participants1275

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (236)

Alabama Neurology Associates PC	Birmingham, Alabama, United States	Recruiting
Ctr for Neurology and Spine	Phoenix, Arizona, United States	Recruiting
AZ Integrated Neuro and Spine	Phoenix, Arizona, United States	Recruiting
Center for Neurosciences	Tucson, Arizona, United States	Recruiting
Fullerton Neuro and Headache Ctr	Fullerton, California, United States	Recruiting
Regina Berkovich MD PhD Inc	West Hollywood, California, United States	Recruiting
UC Health Neuroscience Ctr	Aurora, Colorado, United States	Recruiting
Georgetown University Hospital	Washington D.C., District of Columbia, United States	Recruiting
Medstar Washington Hosp Ctr	Washington D.C., District of Columbia, United States	Recruiting
Neurology of Central FL Res Ctr	Altamonte Springs, Florida, United States	Recruiting
UF Health Cancer Center	Gainesville, Florida, United States	Recruiting
Homestead Assoc In Research Inc	Homestead, Florida, United States	Recruiting

+ 224 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07225504